Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600119610Phase 2Not yet recruiting
Phase 2, randomised, double-blind trial of Dermatophagoides pteronyssinus sublingual film in allergic rhinitis (AR) (5 arms), sponsored by Beijing Tongren Hospital. Primary endpoint: daily average combined scores of rhinitis symptoms and medication. Planned start Feb 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600119610.